Volume 87 Issue 4 | p. 50 | Awards
Issue Date: January 26, 2009

MEDI Announces 2009 Division Awards

Recipients are honored for contributions of major significance to chemistry
Department: ACS News
Macor
Credit: Bristol-Myers Squibb
8704awards2_macorcxd_opt
 
Macor
Credit: Bristol-Myers Squibb
Blagg
Credit: U of Kansas
8704awards2_blaggcxd_opt
 
Blagg
Credit: U of Kansas

The recipients of the 2009 ACS Division of Medicinal Chemistry awards have been selected.

The Robert M. Scarborough Memorial Award will be awarded to John E. Macor, executive director of neuroscience discovery chemistry at Bristol-Myers Squibb. The award recognizes scientists under the age of 50 who have demonstrated success in the discovery of pharmaceutical entities and/or have accrued a substantial body of significant research contributions in medicinal chemistry.

Macor was cited for his discovery of the antimigraine agent Relpax (eletriptan). He will receive a $3,500 honorarium and a plaque during the fall ACS national meeting in Washington, D.C.

Brian S. J. Blagg, an associate professor of medicinal chemistry in the School of Pharmacy at the University of Kansas, will receive the David W. Robertson Memorial Award, which recognizes scientists under the age of 40 who have made substantial contributions to and discoveries in medicinal chemistry.

Blagg is being recognized for his groundbreaking contributions in the discovery of Hsp90 inhibitors. He will receive a $1,000 honorarium and a plaque.

 

Linda Wang compiles this section. Announcements of awards may be sent to l_wang@acs.org.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment